Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.

@article{Palazzuoli2007EffectsOB,
  title={Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.},
  author={Alberto Palazzuoli and Donald S. Silverberg and Francesca Iovine and Anna Maria Calabr{\`o} and Maria Stella Campagna and Maddalena Gallotta and Ranuccio Nuti},
  journal={American heart journal},
  year={2007},
  volume={154 4},
  pages={645.e9-15}
}
BACKGROUND Although anemia is frequently found in congestive heart failure (CHF), little is known about the effect of its correction with erythropoietin (EPO) on cardiac structure and function. OBJECTIVES The present study examines in patients with advanced CHF, chronic renal insufficiency, and anemia the effects of beta-EPO on left ventricular (LV) systolic diameter and volume (LVSD and LVSV), LV diastolic diameter and volume (LVDD and LVDV), LV mass, LV ejection fraction (LVEF), pulmonary… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

Similar Papers

Loading similar papers…